Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial (CAPTIVATE) evaluating the efficacy and safety of DNTH103 in adults with chronic inflammatory demyelinating polyneuropathy, currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Demyelinating Polyneuropathy

Drugs mentioned

• DNTH103

Snippet

Sponsor: Dianthus Therapeutics | Conditions: Chronic Inflammatory Demyelinating Polyneuropathy | Phase 3 | Status: RECRUITING